Filing Details

Accession Number:
0000891293-23-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-26 16:49:57
Reporting Period:
2023-01-24
Accepted Time:
2023-01-26 16:49:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1916577 K James Fong C/O Cti Biopharma Corp
3101 Western Avenue, Suite 800
Seattle WA 98121
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-24 100,000 $0.95 103,565 No 4 M Direct
Common Stock Disposition 2023-01-24 100,000 $6.00 3,565 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2019-02-19 288,000 $0.00 288,000 $0.95
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2023-01-24 100,000 $0.00 100,000 $0.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
288,000 2029-02-19 No 4 A Direct
188,000 2029-02-19 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.
  2. One third of the shares underlying the option vested on 2/19/20 and annually thereafter until all the underlying shares were fully vested on 2/19/2022.